MTSL Issue 867

 Comments Off on MTSL Issue 867
Dec 242017
 
MTSL Issue 867

MTSL Issue 867 (dated 12/21/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #BMRN #INCY #IONS #MDGL #NKTR #NVAX #SGMO #ZIOP

MTSL Issue 866

 Comments Off on MTSL Issue 866
Dec 102017
 
MTSL Issue 866

MTSL Issue 866 (dated 12/07/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ALKS #MDGL #MDCO #NVAX

MTSL Issue 859

 Comments Off on MTSL Issue 859
Sep 032017
 
MTSL Issue 859

MTSL Issue 859 (dated 8/31/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ANTH #BMRN #FPRX #INCY #IONS #DCO NKTR #NVAX SGMO

MTSL Issue 858

 Comments Off on MTSL Issue 858
Aug 202017
 
MTSL Issue 858

MTSL Issue 858 (dated 8/17/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ACAD #ANTH #BMRN #ESPR #FPRX #INCY #IONS #MDCO #MDGL #NKTR #PCRX #SGMO #XON #ZIOP

MTSL Issue 857

 Comments Off on MTSL Issue 857
Jul 302017
 
MTSL Issue 857

MTSL Issue 857 (dated 7/27/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ALKS #ESPR #INCY #IONS #MDCO #NKTR #NVAX #PCRX

Novavax (NVAX) 7-24-17

 Comments Off on Novavax (NVAX) 7-24-17
Jul 272017
 
Novavax (NVAX) 7-24-17

BioInvest News – NVAX – Delivers Some Positive Phase II Immunogenicity Data In COPD…Investors Wanted an RSV Update – NVAX reported top line data from the Phase II older adult safety and immunogenicity trial (E205) demonstrated the benefit of adjuvant formulations and two-dose regimens in patients with RSV and chronic obstructive pulmonary disease (COPD).

MTSL Issue 852

 Comments Off on MTSL Issue 852
May 212017
 
MTSL Issue 852

MTSL Issue 852 (dated 5/18/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #INCY #XON #IONS #NKTR #NVAX #SGMO #ZIOP

MTSL Issue 845

 Comments Off on MTSL Issue 845
Feb 052017
 
MTSL Issue 845

MTSL Issue 845 (dated 2/02/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #INCY #XON #MDCO #NVAX #PCRX

MTSL Issue 840

 Comments Off on MTSL Issue 840
Nov 202016
 
MTSL Issue 840

MTSL Issue 840 (dated 11/17/16) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ANTH #IONS #MDCO #NVAX #ZIOP

MTSL Issue 836

 Comments Off on MTSL Issue 836
Sep 252016
 
MTSL Issue 836

MTSL Issue 836 (dated 9/22/16) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #IONS #MDCO #NVAX #PCRX

MTSL Issue 833

 Comments Off on MTSL Issue 833
Aug 142016
 
MTSL Issue 833

MTSL Issue 833 (dated 8/11/16) of Medical Technology #Stock Letter from BioInvest includes the #Biotech Sector Analysis & updates from these companies: #ACAD #ANTH #BMRN #FPRX #INCY #XON #IONS #MDCO #NKTR #NVAX #PCRX #SGMO #ZIOP

MTSL Issue 829

 Comments Off on MTSL Issue 829
Jun 122016
 
MTSL Issue 829

MTSL Issue 829 (dated 6/09/16) of the Medical Technology #Stock Letter from BioInvest includes the #Biotech Sector Analysis as well as updates from the following companies: #ALKS #FPRX #INCY #IONS #XON #NVAX #MDCO #SGMO #ZIOP

‘Access to Management’ Conference Call with Novavax (NVAX) 6-3-16

 Comments Off on ‘Access to Management’ Conference Call with Novavax (NVAX) 6-3-16
Jun 072016
 
'Access to Management' Conference Call with Novavax (NVAX) 6-3-16

BIOINVEST Access to Management Webinar – Novavax (NVAX)– We are pleased to announce another BioInvest “Access to Management Call.” Below is the link to the recorded webinar presentation with the Senior Management Team of Novavax.

MTSL Issue 828

 Comments Off on MTSL Issue 828
May 292016
 
MTSL Issue 828

MTSL Issue 828 (dated 5/26/16) of the Medical Technology #Stock Letter from BioInvest includes the #Biotech Sector Analysis as well as updates from the following companies: #

Novavax Update (5-16-16)

 Comments Off on Novavax Update (5-16-16)
May 172016
 
Novavax Update (5-16-16)

BIOINVEST BREAKING NEWS – Special Update – NVAX – Q1 Call – Preparing For The Launch Of The RSV Vaccine With Partners In The Wings; We Are In The Zone Read more…